Literature DB >> 10092768

The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade.

S J Kempiak1, T S Hiura, A E Nel.   

Abstract

Costimulation of TCR/CD3 and CD28 receptors leads to activation of the Jun kinase (JNK) cascade, which plays a key role in T cell activation, including activation of the IL-2 promoter. We demonstrate that the JNK cascade plays a central role in the activation of the CD28 response element (CD28RE) in the IL-2 promoter. This response element is linked to an activating protein-1 (AP-1) site, which functions synergistically with the CD28RE. The role of the JNK cascade in the activation of this composite element is twofold: 1) activation of the AP-1 site through transcriptional activation of c-Jun, and 2) activation of the CD28RE through selective cross-talk with I kappa B kinase-beta (IKK beta). Dominant-negative versions of JNK kinase, c-Jun, and IKK beta interfered In CD3- plus CD28-induced CD28RE/AP-1 luciferase activity in Jurkat cells. In contrast, the dominant-active JNK kinase kinase, MEKK1, induced CD28RE/AP-1 luciferase activity, in parallel with induction of c-Jun and c-Rel binding to this combined promoter site. Dominant-active MEKK1 also induced transfected IKK beta, but not IKK alpha, activity. In contrast to the JNK cascade, the extracellular signal-regulated kinase (ERK) cascade did not exert an affect on the CD28RE/AP-1 site, but did contribute to activation of the distal NF-AT/AP-1 site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092768

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways.

Authors:  Sonja I Gringhuis; Ellen A M Papendrecht-van der Voort; Angela Leow; E W Nivine Levarht; Ferdinand C Breedveld; Cornelis L Verweij
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.

Authors:  Li Tao; Scott Wadsworth; Jason Mercer; Cynthia Mueller; Kirsten Lynn; John Siekierka; Avery August
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

3.  Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.

Authors:  A O'Mahony; X Lin; R Geleziunas; W C Greene
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.

Authors:  J H Yeh; P Lecine; J A Nunes; S Spicuglia; P Ferrier; D Olive; J Imbert
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta.

Authors:  X Lin; A O'Mahony; Y Mu; R Geleziunas; W C Greene
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex.

Authors:  S P Hehner; T G Hofmann; A Ushmorov; O Dienz; I Wing-Lan Leung; N Lassam; C Scheidereit; W Dröge; M L Schmitz
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

7.  Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses.

Authors:  Sara Sundström; Seisuke Ota; Lina Y Dimberg; Maria G Masucci; Anders Bergqvist
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.

Authors:  Kenneth A Fowler; Corey M Jania; Stephen L Tilley; Angela Panoskaltsis-Mortari; Albert S Baldwin; Jonathan S Serody; James M Coghill
Journal:  Biol Blood Marrow Transplant       Date:  2017-02-01       Impact factor: 5.742

9.  Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.

Authors:  Andreas Pahl; Meixia Zhang; Hildegard Kuss; Istvan Szelenyi; Kay Brune
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

10.  Mechanisms of rapid induction of interleukin-22 in activated T cells and its modulation by cyclosporin a.

Authors:  Ina Rudloff; Malte Bachmann; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.